查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2106637

寵物保健市場預測至2034年－全球分析（依產品類型、動物種類、治療領域、診斷方法、給藥途徑、應用、最終使用者、通路和地區分類）

Pet Healthcare Market Forecasts to 2034 - Global Analysis By Product (Therapeutics, and Diagnostics), Animal Type, Therapeutic Area, Diagnostic Type, Route of Administration, Application, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球寵物保健市場規模將達到 1,442 億美元，並在預測期內以 7.5% 的複合年成長率成長，到 2034 年將達到 2,572 億美元。

寵物醫療保健涵蓋旨在維護和改善伴侶動物健康與福祉的產品、服務和技術，包括藥物、疫苗、診斷產品、治療性醫療設備和醫療保健服務。該市場涵蓋口服、注射、外用、經皮及其他給藥途徑，應用領域包括預防醫學、疾病診斷、疾病治療、健康管理、復健和恢復。寵物數量的成長、寵物日益「擬人化」、寵物健康支出的增加以及獸醫服務的擴張是推動各地區市場成長的主要因素。

寵物數量的增加以及寵物“擬人化”

全球寵物數量的不斷成長以及將寵物視為家庭成員的趨勢日益盛行，是推動寵物醫療保健市場發展的主要動力。寵物飼主越來越重視預防保健、先進診斷以及與人類醫療標準相媲美的治療方案。寵物「擬人化」的趨勢提高了人們對寵物健康問題的認知，增加了寵物就診頻率，也提高了寵物醫療保健的支出意願。尤其是千禧世代和Z世代的寵物飼主，他們更重視寵物的健康和福祉。隨著已開發國家和開發中國家寵物飼養量的增加，寵物醫療保健產品和服務的目標市場正在不斷擴大，市場成長勢頭強勁。

寵物醫療保健服務和產品高成本

獸醫護理、處方藥和先進治療的高昂費用是限制寵物醫療保健市場發展的主要因素。獸醫就診、診斷程序和外科手術費用昂貴。腫瘤科、心臟科和高級影像等專科醫療服務往往價格不斐。寵物飼主常常需要在承擔治療費用上做出艱難抉擇。保險覆蓋範圍仍然有限，尤其是在發展中地區。這些費用壁壘會限制寵物獲得高品質醫療保健服務的機會，並阻礙市場成長。

拓展遠端醫療和數位化寵物醫療保健解決方案

寵物遠距遠端醫療和數位健康解決方案的日益普及為市場擴張帶來了巨大的機會。遠端醫療能夠實現遠距諮詢、線上後續觀察，並使寵物不受地域限制地獲得獸醫專家的服務。數位健康平台透過提醒、健康追蹤和教育資源來支持預防性護理。與穿戴式裝置的整合則實現了持續的健康監測。新冠疫情加速了遠端醫療的普及，並改變了消費者的預期。隨著數位健康技術的進步和接受度的提高，遠端醫療和寵物數位健康解決方案正在不斷擴大市場佔有率和目標市場。

監管複雜性與產品核可挑戰

動物用藥品和保健品監管環境複雜，對寵物保健市場構成重大威脅。獸藥產品需要獲得監管機構的批准以確保其安全性和有效性，但不同地區的批准要求各不相同。核准流程可能耗時耗力，導致產品上市延遲。學名藥的競爭會影響品牌藥的盈利。監管政策的變更可能會影響現有批准，或需要對配方進行調整。這些監管負擔會減緩新產品的開發和市場准入，尤其對於資源有限的中小型企業而言更是如此。

新型冠狀病毒（COVID-19）的影響：

新冠感染疾病對寵物醫療保健市場產生了重大影響。疫情封鎖期間，寵物數量激增，導致寵物飼養量上升，並催生了新的醫療保健消費者群體。獸醫診所透過實施遠距醫療、路邊服務以及加強感染控制措施來適應這一情況。消費者對健康和保健的關注也延伸到了寵物身上。寵物醫療保健產品的電商銷售額大幅成長。疫情後，寵物飼養量的持續成長和人們健康意識的提高，使得寵物醫療保健需求保持在高位，市場正經歷持續成長。

在預測期內，口腔清潔用品行業預計將佔據最大的市場佔有率。

在預測期內，口服產品預計將佔據最大的市場佔有率。這主要得益於口服保健產品的便利性、易用性以及飼主對其較高的依從性。口服產品包括片劑、咀嚼片、液體和調味料型，方便在家中使用。此細分市場涵蓋預防性治療，例如預防心絲蟲、跳蚤和蜱蟲以及營養補充品。豐富的產品種類和消費者對其產品的熟悉度支撐著持續的需求。隨著寵物飼主尋求便利的保健解決方案，口服產品在給藥途徑細分市場中佔據最大佔有率。

預計在預測期內，預防保健領域將呈現最高的複合年成長率。

在預測期內，預防保健領域預計將呈現最高的成長率，這主要得益於人們對健康益處的認知不斷提高、預防性產品供應更加充足，以及獸醫學界對健康管理的重視程度不斷提升。預防保健包括疫苗接種、寄生蟲防治、牙齒護理、營養補充品和定期健康檢查。獸醫建議優先考慮預防而非治療，這正推動著該領域的成長。寵物保險覆蓋範圍的擴大也促進了預防保健的普及。隨著寵物飼主越來越重視健康維護和預防，該領域正展現出最快的成長速度。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這主要得益於其較高的寵物擁有率、大量的寵物醫療保健支出以及先進的獸醫基礎設施。美國透過對寵物健康的大量投資，正推動著區域市場的成長。寵物飼主對預防保健和先進療法的認知度不斷提高，促進了相關技術的普及應用。眾多獸藥和醫療保健公司的強大實力也為創新提供了支持。完善的獸醫網路和專科轉診系統創造了穩定的需求。憑藉高額的寵物支出和完善的基礎設施，北美將繼續保持其市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於寵物擁有率的上升、可支配收入的增加以及中國、印度、日本和東南亞等國家寵物健康意識的提高。該地區寵物數量的快速成長和中產階級的壯大，正在創造對獸醫產品和服務的巨大需求。獸醫學的現代化和新技術的應用正在加速。人們對預防保健和治療方案的日益重視，也推動了市場擴張。寵物保險參保率的提高和電子商務的普及，提升了服務的可近性。隨著寵物健康產業的發展，亞太地區正經歷全球寵物健康市場最快的成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球寵物保健市場：依產品分類

  • 治療
    • 製藥
    • 生物製劑
    • 營養補充品和膳食補充劑
  • 診斷
    • 裝置
    • 耗材和試劑
    • 診斷軟體和服務

第6章 全球寵物保健市場：依動物類型分類

  • 狗
  • 貓
  • 鳥
  • 馬
  • 小型哺乳動物
  • 爬蟲類
  • 魚
  • 其他伴侶動物

第7章：全球寵物醫療保健市場：依治療領域分類

  • 感染疾病
  • 寄生蟲病
  • 皮膚科
  • 肌肉骨骼疾病
  • 循環系統
  • 腫瘤學
  • 內分泌學
  • 消化系統疾病
  • 呼吸系統疾病
  • 神經病學
  • 其他治療領域

第8章 全球寵物醫療保健市場：依診斷類型分類

  • 臨床化學
  • 血液學
  • 免疫診斷
  • 分子診斷
  • 診斷影像
    • X光
    • 超音波檢查
    • CT
    • MRI
  • 即時檢測
  • 基因檢測
  • 微生物組檢測

第9章：全球寵物保健市場：依給藥途徑分類

  • 口服
  • 注射藥物
  • 外用
  • 經皮給藥
  • 其他給藥途徑

第10章 全球寵物保健市場：按應用分類

  • 預防醫學
  • 疾病診斷
  • 疾病治療
  • 健康管理
  • 復健與恢復

第11章 全球寵物保健市場：依最終用戶分類

  • 獸醫醫院和診所
  • 獸醫診斷檢測實驗室
  • 寵物飼主
  • 動物收容所及救援中心
  • 研究機構和大學

第12章 全球寵物保健市場：依通路分類

  • 獸醫醫院和院內藥房
  • 零售藥局和寵物店
  • 電子商務
  • 其他分銷管道

第13章 全球寵物保健市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第14章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第15章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第16章：公司簡介

  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim Animal Health
  • IDEXX Laboratories, Inc.
  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Ceva Sante Animale
  • Heska Corporation
  • Vetoquinol SA
  • Covetrus, Inc.
  • Neogen Corporation
  • BioChek BV
  • BioNote, Inc.
  • Bimeda, Inc.
  • Norbrook Laboratories Ltd.
Product Code: SMRC38703

According to Stratistics MRC, the Global Pet Healthcare Market is accounted for $144.2 billion in 2026 and is expected to reach $257.2 billion by 2034 growing at a CAGR of 7.5% during the forecast period. Pet healthcare encompasses products, services, and technologies designed to maintain and improve the health and well-being of companion animals, including pharmaceuticals, vaccines, diagnostic products, therapeutic devices, and healthcare services. The market covers various routes of administration including oral, injectable, topical, transdermal, and other methods across applications including preventive care, disease diagnosis, disease treatment, wellness management, and rehabilitation and recovery. Growing pet ownership, increasing humanization of pets, rising expenditure on pet health, and expanding veterinary services are key drivers of market expansion across all regions.

Market Dynamics:

Driver:

Increasing pet ownership and humanization of pets

The rising global pet population and growing trend of treating pets as family members are primary drivers for the pet healthcare market. Pet owners are increasingly investing in preventive care, advanced diagnostics, and treatment options that mirror human healthcare standards. The humanization of pets has led to greater awareness of health issues, increased veterinary visits, and higher willingness to spend on medical care. Millennials and Gen Z pet owners, in particular, prioritize pet health and wellness. As pet ownership increases across developed and developing regions, the addressable market for pet healthcare products and services expands, sustaining strong market growth.

Restraint:

High costs of pet healthcare services and products

The significant costs associated with veterinary care, prescription medications, and advanced treatments represent a major restraint for the pet healthcare market. Veterinary visits, diagnostic procedures, and surgical interventions require substantial financial commitment. Specialty care including oncology, cardiology, and advanced imaging is often prohibitively expensive. Pet owners may face difficult decisions about treatment affordability. Insurance coverage remains limited, particularly in developing regions. These cost barriers may limit access to quality pet healthcare, affecting market growth.

Opportunity:

Expansion of telemedicine and digital pet healthcare solutions

The growing adoption of telemedicine and digital health solutions for pets presents significant opportunities for market expansion. Telemedicine enables remote consultations, virtual follow-ups, and access to veterinary specialists regardless of geographic location. Digital health platforms support preventive care through reminders, wellness tracking, and educational resources. Integration with wearable devices enables continuous health monitoring. The COVID-19 pandemic accelerated telemedicine adoption, changing consumer expectations. As digital health technologies advance and acceptance grows, telemedicine and digital pet healthcare solutions capture growing market share, expanding the addressable market.

Threat:

Regulatory complexities and product approval challenges

The complex regulatory landscape governing veterinary pharmaceuticals and healthcare products poses significant threats to the pet healthcare market. Veterinary products require safety and efficacy approval from regulatory authorities, with varying requirements across jurisdictions. Approval processes can be lengthy and costly, delaying product launches. Generic competition may affect branded product profitability. Regulatory changes can affect existing approvals or require reformulation. These regulatory burdens may slow new product development and market entry, particularly for smaller companies with limited resources.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the pet healthcare market. Pet adoption surged during lockdowns, expanding the pet population and creating new healthcare consumers. Veterinary practices adapted with telemedicine, curbside service, and enhanced infection control. Consumer focus on health and wellness extended to pets. E-commerce sales of pet healthcare products increased dramatically. Post-pandemic, elevated pet ownership levels and continued health awareness have sustained increased demand for pet healthcare, with the market experiencing continued growth.

The Oral segment is expected to be the largest during the forecast period

The Oral segment is expected to account for the largest market share during the forecast period, driven by the convenience, ease of administration, and high owner compliance associated with oral pet healthcare products. Oral administration includes tablets, chewables, liquids, and flavored formulations that are easily administered at home. The segment encompasses preventive treatments including heartworm preventives, flea and tick control, and nutritional supplements. The range of available products and established consumer familiarity support sustained demand. As pet owners seek convenient healthcare solutions, oral administration maintains the largest route segment share.

The Preventive Care segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Preventive Care segment is predicted to witness the highest growth rate, fueled by increasing awareness of the benefits of preventive healthcare, growing availability of preventive products, and shifting focus toward wellness management in veterinary medicine. Preventive care includes vaccines, parasite control, dental care, nutritional supplements, and regular health screenings. The segment benefits from veterinary recommendations emphasizing prevention over treatment. Growing pet insurance coverage supports preventive care adoption. As pet owners increasingly prioritize wellness and prevention, this segment delivers the fastest application growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, strong spending on pet healthcare, and advanced veterinary healthcare infrastructure. The United States leads regional market growth with substantial investment in pet health. High awareness of preventive care and advanced treatment options among pet owners drives adoption. Strong presence of veterinary pharmaceutical and healthcare companies supports innovation. Established veterinary networks and specialist referral systems create consistent demand. With high pet spending and advanced infrastructure, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, increasing disposable incomes, and growing awareness of pet healthcare across countries including China, India, Japan, and Southeast Asia. The region's rapidly growing pet population and expanding middle class create substantial demand for veterinary products and services. Veterinary practice modernization and technology adoption are accelerating. Growing awareness of preventive care and treatment options supports market expansion. Rising pet insurance adoption and e-commerce penetration increase accessibility. As pet healthcare develops, Asia Pacific delivers the fastest pet healthcare market growth globally.

Key players in the market

Some of the key players in Pet Healthcare Market include Zoetis Inc., Merck Animal Health, Elanco Animal Health Incorporated, Boehringer Ingelheim Animal Health, IDEXX Laboratories, Inc., Virbac S.A., Dechra Pharmaceuticals PLC, Ceva Sante Animale, Heska Corporation, Vetoquinol S.A., Covetrus, Inc., Neogen Corporation, BioChek B.V., BioNote, Inc., Bimeda, Inc., and Norbrook Laboratories Ltd.

Key Developments:

In June 2026, Elanco Animal Health announced plans to launch Elanco Ventures with a $25 million multi-year commitment, establishing a corporate venture capital platform dedicated to funding early-stage startups and accelerating innovation across therapeutics, digital tools, and One Health initiatives.

In May 2026, IDEXX Laboratories expanded its Fecal Dx antigen testing platform to include Taeniid tapeworm detection, enhancing non-invasive gastrointestinal parasite screening for veterinary practices.

In March 2026, Merck Animal Health received FDA approval for NUMELVI(TM) (atinvicitinib tablets), making it the first second-generation Janus Kinase (JAK) inhibitor for controlling pruritus associated with allergic dermatitis in dogs.

In January 2026, IDEXX Laboratories introduced a comprehensive diagnostic panel for canine mast cell tumors, advancing precision oncology and tailored treatment planning in veterinary medicine.

Products Covered:

  • Therapeutics
  • Diagnostics

Animal Types Covered:

  • Dogs
  • Cats
  • Birds
  • Horses
  • Small Mammals
  • Reptiles
  • Fish
  • Other Companion Animals

Therapeutic Areas Covered:

  • Infectious Diseases
  • Parasitic Diseases
  • Dermatology
  • Musculoskeletal Disorders
  • Cardiology
  • Oncology
  • Endocrinology
  • Gastrointestinal Disorders
  • Respiratory Disorders
  • Neurology
  • Other Therapeutic Areas

Diagnostic Types Covered:

  • Clinical Chemistry
  • Hematology
  • Immunodiagnostics
  • Molecular Diagnostics
  • Diagnostic Imaging
  • Point-of-Care Testing
  • Genetic Testing
  • Microbiome Testing

Routes of Administration Covered:

  • Oral
  • Injectable
  • Topical
  • Transdermal
  • Other Routes

Applications Covered:

  • Preventive Care
  • Disease Diagnosis
  • Disease Treatment
  • Wellness Management
  • Rehabilitation and Recovery

End Users Covered:

  • Veterinary Hospitals and Clinics
  • Veterinary Diagnostic Laboratories
  • Pet Owners
  • Animal Shelters and Rescue Centers
  • Research Institutes and Universities

Distribution Channels Covered:

  • Veterinary Hospitals and Clinic Pharmacies
  • Retail Pharmacies and Pet Stores
  • E-Commerce
  • Other Distribution Channels

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pet Healthcare Market, By Product

  • 5.1 Therapeutics
    • 5.1.1 Pharmaceuticals
    • 5.1.2 Biologics
    • 5.1.3 Nutraceuticals and Supplements
  • 5.2 Diagnostics
    • 5.2.1 Instruments
    • 5.2.2 Consumables and Reagents
    • 5.2.3 Diagnostic Software and Services

6 Global Pet Healthcare Market, By Animal Type

  • 6.1 Dogs
  • 6.2 Cats
  • 6.3 Birds
  • 6.4 Horses
  • 6.5 Small Mammals
  • 6.6 Reptiles
  • 6.7 Fish
  • 6.8 Other Companion Animals

7 Global Pet Healthcare Market, By Therapeutic Area

  • 7.1 Infectious Diseases
  • 7.2 Parasitic Diseases
  • 7.3 Dermatology
  • 7.4 Musculoskeletal Disorders
  • 7.5 Cardiology
  • 7.6 Oncology
  • 7.7 Endocrinology
  • 7.8 Gastrointestinal Disorders
  • 7.9 Respiratory Disorders
  • 7.10 Neurology
  • 7.11 Other Therapeutic Areas

8 Global Pet Healthcare Market, By Diagnostic Type

  • 8.1 Clinical Chemistry
  • 8.2 Hematology
  • 8.3 Immunodiagnostics
  • 8.4 Molecular Diagnostics
  • 8.5 Diagnostic Imaging
    • 8.5.1 X-ray
    • 8.5.2 Ultrasound
    • 8.5.3 CT
    • 8.5.4 MRI
  • 8.6 Point-of-Care Testing
  • 8.7 Genetic Testing
  • 8.8 Microbiome Testing

9 Global Pet Healthcare Market, By Route of Administration

  • 9.1 Oral
  • 9.2 Injectable
  • 9.3 Topical
  • 9.4 Transdermal
  • 9.5 Other Routes

10 Global Pet Healthcare Market, By Application

  • 10.1 Preventive Care
  • 10.2 Disease Diagnosis
  • 10.3 Disease Treatment
  • 10.4 Wellness Management
  • 10.5 Rehabilitation and Recovery

11 Global Pet Healthcare Market, By End User

  • 11.1 Veterinary Hospitals and Clinics
  • 11.2 Veterinary Diagnostic Laboratories
  • 11.3 Pet Owners
  • 11.4 Animal Shelters and Rescue Centers
  • 11.5 Research Institutes and Universities

12 Global Pet Healthcare Market, By Distribution Channel

  • 12.1 Veterinary Hospitals and Clinic Pharmacies
  • 12.2 Retail Pharmacies and Pet Stores
  • 12.3 E-Commerce
  • 12.4 Other Distribution Channels

13 Global Pet Healthcare Market, By Geography

  • 13.1 North America
    • 13.1.1 United States
    • 13.1.2 Canada
    • 13.1.3 Mexico
  • 13.2 Europe
    • 13.2.1 United Kingdom
    • 13.2.2 Germany
    • 13.2.3 France
    • 13.2.4 Italy
    • 13.2.5 Spain
    • 13.2.6 Netherlands
    • 13.2.7 Belgium
    • 13.2.8 Sweden
    • 13.2.9 Switzerland
    • 13.2.10 Poland
    • 13.2.11 Rest of Europe
  • 13.3 Asia Pacific
    • 13.3.1 China
    • 13.3.2 Japan
    • 13.3.3 India
    • 13.3.4 South Korea
    • 13.3.5 Australia
    • 13.3.6 Indonesia
    • 13.3.7 Thailand
    • 13.3.8 Malaysia
    • 13.3.9 Singapore
    • 13.3.10 Vietnam
    • 13.3.11 Rest of Asia Pacific
  • 13.4 South America
    • 13.4.1 Brazil
    • 13.4.2 Argentina
    • 13.4.3 Colombia
    • 13.4.4 Chile
    • 13.4.5 Peru
    • 13.4.6 Rest of South America
  • 13.5 Rest of the World (RoW)
    • 13.5.1 Middle East
      • 13.5.1.1 Saudi Arabia
      • 13.5.1.2 United Arab Emirates
      • 13.5.1.3 Qatar
      • 13.5.1.4 Israel
      • 13.5.1.5 Rest of Middle East
    • 13.5.2 Africa
      • 13.5.2.1 South Africa
      • 13.5.2.2 Egypt
      • 13.5.2.3 Morocco
      • 13.5.2.4 Rest of Africa

14 Strategic Market Intelligence

  • 14.1 Industry Value Network and Supply Chain Assessment
  • 14.2 White-Space and Opportunity Mapping
  • 14.3 Product Evolution and Market Life Cycle Analysis
  • 14.4 Channel, Distributor, and Go-to-Market Assessment

15 Industry Developments and Strategic Initiatives

  • 15.1 Mergers and Acquisitions
  • 15.2 Partnerships, Alliances, and Joint Ventures
  • 15.3 New Product Launches and Certifications
  • 15.4 Capacity Expansion and Investments
  • 15.5 Other Strategic Initiatives

16 Company Profiles

  • 16.1 Zoetis Inc.
  • 16.2 Merck Animal Health
  • 16.3 Elanco Animal Health Incorporated
  • 16.4 Boehringer Ingelheim Animal Health
  • 16.5 IDEXX Laboratories, Inc.
  • 16.6 Virbac S.A.
  • 16.7 Dechra Pharmaceuticals PLC
  • 16.8 Ceva Sante Animale
  • 16.9 Heska Corporation
  • 16.10 Vetoquinol S.A.
  • 16.11 Covetrus, Inc.
  • 16.12 Neogen Corporation
  • 16.13 BioChek B.V.
  • 16.14 BioNote, Inc.
  • 16.15 Bimeda, Inc.
  • 16.16 Norbrook Laboratories Ltd.

List of Tables

  • Table 1 Global Pet Healthcare Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pet Healthcare Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Pet Healthcare Market Outlook, By Therapeutics (2023-2034) ($MN)
  • Table 4 Global Pet Healthcare Market Outlook, By Pharmaceuticals (2023-2034) ($MN)
  • Table 5 Global Pet Healthcare Market Outlook, By Biologics (2023-2034) ($MN)
  • Table 6 Global Pet Healthcare Market Outlook, By Nutraceuticals and Supplements (2023-2034) ($MN)
  • Table 7 Global Pet Healthcare Market Outlook, By Diagnostics (2023-2034) ($MN)
  • Table 8 Global Pet Healthcare Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 9 Global Pet Healthcare Market Outlook, By Consumables and Reagents (2023-2034) ($MN)
  • Table 10 Global Pet Healthcare Market Outlook, By Diagnostic Software and Services (2023-2034) ($MN)
  • Table 11 Global Pet Healthcare Market Outlook, By Animal Type (2023-2034) ($MN)
  • Table 12 Global Pet Healthcare Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 13 Global Pet Healthcare Market Outlook, By Cats (2023-2034) ($MN)
  • Table 14 Global Pet Healthcare Market Outlook, By Birds (2023-2034) ($MN)
  • Table 15 Global Pet Healthcare Market Outlook, By Horses (2023-2034) ($MN)
  • Table 16 Global Pet Healthcare Market Outlook, By Small Mammals (2023-2034) ($MN)
  • Table 17 Global Pet Healthcare Market Outlook, By Reptiles (2023-2034) ($MN)
  • Table 18 Global Pet Healthcare Market Outlook, By Fish (2023-2034) ($MN)
  • Table 19 Global Pet Healthcare Market Outlook, By Other Companion Animals (2023-2034) ($MN)
  • Table 20 Global Pet Healthcare Market Outlook, By Therapeutic Area (2023-2034) ($MN)
  • Table 21 Global Pet Healthcare Market Outlook, By Infectious Diseases (2023-2034) ($MN)
  • Table 22 Global Pet Healthcare Market Outlook, By Parasitic Diseases (2023-2034) ($MN)
  • Table 23 Global Pet Healthcare Market Outlook, By Dermatology (2023-2034) ($MN)
  • Table 24 Global Pet Healthcare Market Outlook, By Musculoskeletal Disorders (2023-2034) ($MN)
  • Table 25 Global Pet Healthcare Market Outlook, By Cardiology (2023-2034) ($MN)
  • Table 26 Global Pet Healthcare Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 27 Global Pet Healthcare Market Outlook, By Endocrinology (2023-2034) ($MN)
  • Table 28 Global Pet Healthcare Market Outlook, By Gastrointestinal Disorders (2023-2034) ($MN)
  • Table 29 Global Pet Healthcare Market Outlook, By Respiratory Disorders (2023-2034) ($MN)
  • Table 30 Global Pet Healthcare Market Outlook, By Neurology (2023-2034) ($MN)
  • Table 31 Global Pet Healthcare Market Outlook, By Other Therapeutic Areas (2023-2034) ($MN)
  • Table 32 Global Pet Healthcare Market Outlook, By Diagnostic Type (2023-2034) ($MN)
  • Table 33 Global Pet Healthcare Market Outlook, By Clinical Chemistry (2023-2034) ($MN)
  • Table 34 Global Pet Healthcare Market Outlook, By Hematology (2023-2034) ($MN)
  • Table 35 Global Pet Healthcare Market Outlook, By Immunodiagnostics (2023-2034) ($MN)
  • Table 36 Global Pet Healthcare Market Outlook, By Molecular Diagnostics (2023-2034) ($MN)
  • Table 37 Global Pet Healthcare Market Outlook, By Diagnostic Imaging (2023-2034) ($MN)
  • Table 38 Global Pet Healthcare Market Outlook, By X-ray (2023-2034) ($MN)
  • Table 39 Global Pet Healthcare Market Outlook, By Ultrasound (2023-2034) ($MN)
  • Table 40 Global Pet Healthcare Market Outlook, By CT (2023-2034) ($MN)
  • Table 41 Global Pet Healthcare Market Outlook, By MRI (2023-2034) ($MN)
  • Table 42 Global Pet Healthcare Market Outlook, By Point-of-Care Testing (2023-2034) ($MN)
  • Table 43 Global Pet Healthcare Market Outlook, By Genetic Testing (2023-2034) ($MN)
  • Table 44 Global Pet Healthcare Market Outlook, By Microbiome Testing (2023-2034) ($MN)
  • Table 45 Global Pet Healthcare Market Outlook, By Route of Administration (2023-2034) ($MN)
  • Table 46 Global Pet Healthcare Market Outlook, By Oral (2023-2034) ($MN)
  • Table 47 Global Pet Healthcare Market Outlook, By Injectable (2023-2034) ($MN)
  • Table 48 Global Pet Healthcare Market Outlook, By Topical (2023-2034) ($MN)
  • Table 49 Global Pet Healthcare Market Outlook, By Transdermal (2023-2034) ($MN)
  • Table 50 Global Pet Healthcare Market Outlook, By Other Routes (2023-2034) ($MN)
  • Table 51 Global Pet Healthcare Market Outlook, By Application (2023-2034) ($MN)
  • Table 52 Global Pet Healthcare Market Outlook, By Preventive Care (2023-2034) ($MN)
  • Table 53 Global Pet Healthcare Market Outlook, By Disease Diagnosis (2023-2034) ($MN)
  • Table 54 Global Pet Healthcare Market Outlook, By Disease Treatment (2023-2034) ($MN)
  • Table 55 Global Pet Healthcare Market Outlook, By Wellness Management (2023-2034) ($MN)
  • Table 56 Global Pet Healthcare Market Outlook, By Rehabilitation and Recovery (2023-2034) ($MN)
  • Table 57 Global Pet Healthcare Market Outlook, By End User (2023-2034) ($MN)
  • Table 58 Global Pet Healthcare Market Outlook, By Veterinary Hospitals and Clinics (2023-2034) ($MN)
  • Table 59 Global Pet Healthcare Market Outlook, By Veterinary Diagnostic Laboratories (2023-2034) ($MN)
  • Table 60 Global Pet Healthcare Market Outlook, By Pet Owners (2023-2034) ($MN)
  • Table 61 Global Pet Healthcare Market Outlook, By Animal Shelters and Rescue Centers (2023-2034) ($MN)
  • Table 62 Global Pet Healthcare Market Outlook, By Research Institutes and Universities (2023-2034) ($MN)
  • Table 63 Global Pet Healthcare Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 64 Global Pet Healthcare Market Outlook, By Veterinary Hospitals and Clinic Pharmacies (2023-2034) ($MN)
  • Table 65 Global Pet Healthcare Market Outlook, By Retail Pharmacies and Pet Stores (2023-2034) ($MN)
  • Table 66 Global Pet Healthcare Market Outlook, By E-Commerce (2023-2034) ($MN)
  • Table 67 Global Pet Healthcare Market Outlook, By Other Distribution Channels (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.